[{"uuid": "37a752bc-9046-3b53-a21b-9905691e030e", "title": "Applied Therapeutics Appoints Reena Thomas Colacot as Vice President and Head of Quality", "publisher": "GlobeNewswire", "link": "https://finance.yahoo.com/news/applied-therapeutics-appoints-reena-thomas-120000865.html", "providerPublishTime": 1737460800, "type": "STORY", "thumbnail": {"resolutions": [{"url": "https://s.yimg.com/uu/api/res/1.2/rd.zdem6H.5iAKsFPsV9ow--~B/aD00NDc7dz0xNjU0O2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/globenewswire.com/a642cfd9ca59150b84905e0421c4fb34", "width": 1654, "height": 447, "tag": "original"}, {"url": "https://s.yimg.com/uu/api/res/1.2/8EH4zt2s7sDLtOlJm8IoAQ--~B/Zmk9ZmlsbDtoPTE0MDtweW9mZj0wO3c9MTQwO2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/globenewswire.com/a642cfd9ca59150b84905e0421c4fb34", "width": 140, "height": 140, "tag": "140x140"}]}, "relatedTickers": ["APLT"]}, {"uuid": "71c42293-d62b-3231-9a8a-9071163c8e94", "title": "Is Applied Therapeutics (APLT) the Best Penny Stock to Invest In According to Media?", "publisher": "Insider Monkey", "link": "https://finance.yahoo.com/news/applied-therapeutics-aplt-best-penny-125040798.html", "providerPublishTime": 1736340640, "type": "STORY", "thumbnail": {"resolutions": [{"url": "https://s.yimg.com/uu/api/res/1.2/PGQQGpUYNvbtn5E3QqvSdA--~B/aD04MTY7dz0xNDU2O2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/insidermonkey.com/7c2522da34920797201edde15d9e3722", "width": 1456, "height": 816, "tag": "original"}, {"url": "https://s.yimg.com/uu/api/res/1.2/TgX9Nk5Owvd9SkN5vFMcBg--~B/Zmk9ZmlsbDtoPTE0MDtweW9mZj0wO3c9MTQwO2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/insidermonkey.com/7c2522da34920797201edde15d9e3722", "width": 140, "height": 140, "tag": "140x140"}]}, "relatedTickers": ["APLT", "^RUT", "^GSPC"]}, {"uuid": "24a8519a-da5d-3af2-9e5a-7a8aaa263348", "title": "Here\u2019s Why Applied Therapeutics, Inc. (NASDAQ:APLT) Is Among the Best Diabetes Stocks to Buy Under $10", "publisher": "Insider Monkey", "link": "https://finance.yahoo.com/news/why-applied-therapeutics-inc-nasdaq-141326761.html", "providerPublishTime": 1736172806, "type": "STORY", "thumbnail": {"resolutions": [{"url": "https://s.yimg.com/uu/api/res/1.2/nzk2aeegYaje.LiEf3oHDQ--~B/aD04MTY7dz0xNDU2O2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/insidermonkey.com/bd2d9661f11e728786ccfadde88fc62e", "width": 1456, "height": 816, "tag": "original"}, {"url": "https://s.yimg.com/uu/api/res/1.2/9VuITs3rQzOHLbIMP8K.Pw--~B/Zmk9ZmlsbDtoPTE0MDtweW9mZj0wO3c9MTQwO2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/insidermonkey.com/bd2d9661f11e728786ccfadde88fc62e", "width": 140, "height": 140, "tag": "140x140"}]}, "relatedTickers": ["APLT"]}, {"uuid": "8151c228-bf6c-360f-8e67-bbbc2398c2e3", "title": "William Blair Downgrades Applied Therapeutics to Market Perform From Outperform", "publisher": "MT Newswires", "link": "https://finance.yahoo.com/news/william-blair-downgrades-applied-therapeutics-121140761.html", "providerPublishTime": 1734955900, "type": "STORY", "relatedTickers": ["APLT"]}, {"uuid": "3501e4fd-1aab-337f-88c2-c6ece3e53e5c", "title": "Applied Therapeutics Names John Johnson as Executive Chair, Les Funtleyder as Interim CEO", "publisher": "MT Newswires", "link": "https://finance.yahoo.com/news/applied-therapeutics-names-john-johnson-124534637.html", "providerPublishTime": 1734698734, "type": "STORY", "relatedTickers": ["APLT"]}, {"uuid": "e1e4eabd-0f78-3f4b-8160-6b6711db2e43", "title": "APLT Stock Plunges 77% After FDA Issues CRL for Galactosemia Drug NDA", "publisher": "Zacks", "link": "https://finance.yahoo.com/news/aplt-stock-plunges-77-fda-151300400.html", "providerPublishTime": 1732806780, "type": "STORY", "thumbnail": {"resolutions": [{"url": "https://s.yimg.com/uu/api/res/1.2/T8SwUImUDIjgxL38j1nI4w--~B/aD00MTQ7dz02MjA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/zacks.com/17664ed95646b97db9beb170298a16b3", "width": 620, "height": 414, "tag": "original"}, {"url": "https://s.yimg.com/uu/api/res/1.2/OZvURUKXAwPcSmvMZ21lzg--~B/Zmk9ZmlsbDtoPTE0MDtweW9mZj0wO3c9MTQwO2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/zacks.com/17664ed95646b97db9beb170298a16b3", "width": 140, "height": 140, "tag": "140x140"}]}, "relatedTickers": ["APLT"]}, {"uuid": "13dd8fdc-16ea-3fb0-ba4a-c2f90bc0a61d", "title": "RBC Cuts Price Target on Applied Therapeutics to $1.50 From $4, Keeps Sector Perform, Speculative Risk", "publisher": "MT Newswires", "link": "https://finance.yahoo.com/news/rbc-cuts-price-target-applied-124010292.html", "providerPublishTime": 1734698410, "type": "STORY", "relatedTickers": ["APLT"]}, {"uuid": "8f7bec48-07f1-3fe2-8394-e0bf04e0d341", "title": "Applied Therapeutics Appoints John H. Johnson as Executive Chairman", "publisher": "GlobeNewswire", "link": "https://finance.yahoo.com/news/applied-therapeutics-appoints-john-h-120000070.html", "providerPublishTime": 1734696000, "type": "STORY", "thumbnail": {"resolutions": [{"url": "https://s.yimg.com/uu/api/res/1.2/rd.zdem6H.5iAKsFPsV9ow--~B/aD00NDc7dz0xNjU0O2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/globenewswire.com/a642cfd9ca59150b84905e0421c4fb34", "width": 1654, "height": 447, "tag": "original"}, {"url": "https://s.yimg.com/uu/api/res/1.2/8EH4zt2s7sDLtOlJm8IoAQ--~B/Zmk9ZmlsbDtoPTE0MDtweW9mZj0wO3c9MTQwO2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/globenewswire.com/a642cfd9ca59150b84905e0421c4fb34", "width": 140, "height": 140, "tag": "140x140"}]}, "relatedTickers": ["RVPH", "RVPHW", "VSTM", "APLT"]}, {"uuid": "87c0a8ad-a703-3912-959b-8bbba25ee61c", "title": "Penny Stock Applied Therapeutics' FDA Troubles Trigger Investor Lawsuit, Shareholders Claim Deception Over Govorestat Clinical Data", "publisher": "Benzinga", "link": "https://finance.yahoo.com/news/penny-stock-applied-therapeutics-fda-221551580.html", "providerPublishTime": 1734732951, "type": "STORY", "thumbnail": {"resolutions": [{"url": "https://s.yimg.com/uu/api/res/1.2/UajFcVXyBbGW._8YHZnAzA--~B/aD01NTM7dz05ODM7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/Benzinga/d3cae5694e766314b62be2ea5ce66552", "width": 983, "height": 553, "tag": "original"}, {"url": "https://s.yimg.com/uu/api/res/1.2/avDmTXw8fJBNxJe9ORIS_w--~B/Zmk9ZmlsbDtoPTE0MDtweW9mZj0wO3c9MTQwO2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/Benzinga/d3cae5694e766314b62be2ea5ce66552", "width": 140, "height": 140, "tag": "140x140"}]}, "relatedTickers": ["APLT"]}, {"uuid": "35a3d35d-a62b-34c5-acdf-d2e04c127610", "title": "Top Premarket Decliners", "publisher": "MT Newswires", "link": "https://finance.yahoo.com/news/top-premarket-decliners-131036512.html", "providerPublishTime": 1734959436, "type": "STORY"}, {"uuid": "712bd1cf-c47f-3d4d-863f-782717853072", "title": "Pony AI, Thermo Fisher initiated: Wall Street's top analyst calls", "publisher": "The Fly", "link": "https://finance.yahoo.com/news/pony-ai-thermo-fisher-initiated-143543015.html", "providerPublishTime": 1734964543, "type": "STORY", "thumbnail": {"resolutions": [{"url": "https://s.yimg.com/uu/api/res/1.2/zUit8GQVW5kcaTZHEPMI9Q--~B/aD02Mjg7dz0xMjAwO2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/the_fly_169/5039a5ccc6ec98e1b92bc672330bfcec", "width": 1200, "height": 628, "tag": "original"}, {"url": "https://s.yimg.com/uu/api/res/1.2/IPH9wCP.ftudEFOX7xr1MA--~B/Zmk9ZmlsbDtoPTE0MDtweW9mZj0wO3c9MTQwO2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/the_fly_169/5039a5ccc6ec98e1b92bc672330bfcec", "width": 140, "height": 140, "tag": "140x140"}]}, "relatedTickers": ["TMO"]}, {"uuid": "a5c8990e-6a54-38e8-b10e-6b8a4631da9e", "title": "Applied Therapeutics Faces Uncertainty After US FDA Rejects NDA for Govorestat in Galactosemia, UBS Says", "publisher": "MT Newswires", "link": "https://finance.yahoo.com/news/applied-therapeutics-faces-uncertainty-us-171638840.html", "providerPublishTime": 1733159798, "type": "STORY", "relatedTickers": ["APLT"]}]